China’s unprecedented crackdown on its online presence has depressed financiers and entrepreneurs banking on once- premium sectors such as gaming and e-commerce. However, venture capitalists are not letting down in the region. During the consumer digital revolution of the 2010s, moguls like as Tencent and Alibaba emerged. As technology expands to more conventional industries, new behemoths will emerge in the “technology” market as a whole.
Temasek, for instance, sees a “great number of opportunities” in fields such as sustainability, healthcare, biotech and medical technologies in China, according to chairman Sipahimalani Rohit, who recently spoke with Nikkei Asia. These are fields that “remain consistent with public policy.”
Matter of fact, Temasek just last week invested in a number of Chinese start-ups in these industries, including optometry device supplier called Vision X. mRNA-based immunisation and drug provider called Abogen Biosciences; a surgical cyborg developer called Edge Medical Robotics; a self-driving technology provider called Momenta.
China was the largest regional source of investment for Singapore government-owned firms as of 31st of March, holding 27 percent of its 381 billion US dollars (280 billion US dollars) investment strategy.
Temasek, on the other hand, is stopping fund allocation in information start-ups in the midst of a legislative change.